In addition, the reduction in tau has been found to protect neurons from the loss of mitochondrial membrane potential [85], excitotoxicity [86], and axonal transport inhibition [87] induced by Aβ [88], indicating that tau is a critical target for AD treatment. Here, MAPT is linked to Alzheimer disease.